Author

Elisabeth Ehrend

Observed names: E Ehrend, E. Ehrend, Ehrend, Elisabeth

Institution: German Red Cross

Observed institutions: Goethe University Frankfurt, German Red Cross

ORCID: 0009-0009-0129-2774

Observed ORCID: 0009-0009-0129-2774

OpenAlex ID: A5000189954

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing

2021 · Elisabeth Ehrend, Patricia Manns, et al. · Blood · 13

Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor

2025 · Eric Bräuchle, Maria Knaub, et al. · Bioengineering · 3

Real World Product Quality Data of Car-engineered Nk Cells for Intracranial Injection in Patients With Recurrent Her2-positive Glioblastoma From the Ongoing Car2brain Clinical Trial

2024 · E. Ehrend, P. Manns, et al. · Cytotherapy · 3

Repetitive Intracranial Injection of Natural Killer Cells Engineered With a Her2-targeted Chimeric Antigen Receptor Alone and in Combination With Systemic Anti-pd-1 Checkpoint Inhibition in Patients With Recurrent Glioblastoma

2026 · M. Burger, E. Ehrend, et al. · Cytotherapy · 1

Ks05.5.a Repetitive Intracranial Injection of Natural Killer Cells Engineered With a Her2-targeted Chimeric Antigen Receptor Alone and in Combination With Systemic Anti-pd-1 Checkpoint Inhibition in Patients With Recurrent Glioblastoma

2024 · M C Burger, E Ehrend, et al. · Neuro-Oncology · 1

Gmp-compliant Automated Large Scale Expansion of Car-nk-92 Cells for the Treatment of Her2-positive Solid Tumors Using the Quantum Flex Cell Expansion System

2026 · E. Ehrend, E. Bräuchle, et al. · Cytotherapy

Correction: Bräuchle et al. Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor. Bioengineering 2025, 12, 644

2025 · Eric Bräuchle, Maria Knaub, et al. · Bioengineering

Ctim-04. Modulation of the Intratumoral Immune Microenvironment by Local Therapy With Natural Killer Cells Engineered With a Her2-targeted Chimeric Antigen Receptor in Combination With Systemic Anti-pd-1 Checkpoint Inhibition in Patients With Recurrent Glioblastoma

2024 · Michael Burger, Elisabeth Ehrend, et al. · Neuro-Oncology

Entwicklung eines innovativen Testsystems für die Detektion, Spezifikation und Depletion von erythrozytären, thrombozytären, granulozytären undtherapeutischen Antikörpern

2023 · Ehrend, Elisabeth · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)

Works count: 9

Citation count: 21

H-index: 3

I10-index: 1